During the past decade, University of South Florida Diabetes Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of South Florida Diabetes Center" #1 sponsor was "Medtronic Diabetes" with 4 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Mannkind Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of South Florida Diabetes Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator, "American Diabetes Association" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "University of South Florida Diabetes Center" are "Type 1 Diabetes" (4 trials), "Type 1 Diabetes Mellitus" (3 trials), "Diabetes Mellitus, Type 1" (2 trials), "Growth Hormone Deficiency" (1 trials) and "New-onset Type 1 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "University of South Florida Diabetes Center" in a lesser frequency.

Most popular intervention types in "University of South Florida Diabetes Center" are "Device" (5 trials), "Drug" (5 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "670G and 770G Insulin Pump" (1 trials), "Afrezza" (1 trials), "Anti-Thymocyte Globulin (ATG)" (1 trials) and "Cloud-based Digital Twin and Meal Prediction algorithms" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of South Florida Diabetes Center" are 12 trials for "All" genders.

Currently, there are NaN active trials in "University of South Florida Diabetes Center". 1 are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of South Florida Diabetes Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of South Florida Diabetes Center, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".